Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

2(28.6%)

N/A

2(28.6%)

Phase 1

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 3(2)

N/A(2)

Phase 1(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05629533Terminated

The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output

Role: collaborator

NCT02475434Not ApplicableCompleted

Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants

Role: collaborator

NCT06181994Recruiting

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Role: collaborator

NCT04249232Phase 2Completed

Abaloparatide and Pelvic Fracture Healing

Role: collaborator

NCT05977400Phase 3Not Yet Recruiting

NICU Antibiotics and Outcomes (NANO) Follow-up Study

Role: collaborator

NCT01994954Not ApplicableCompleted

A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants

Role: collaborator

NCT03390530Phase 3Withdrawn

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

Role: collaborator

NCT03056378Phase 1Withdrawn

POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units

Role: collaborator

NCT04071600Phase 1Unknown

Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder

Role: collaborator

All 9 trials loaded